11.47
20-September-24 14:59:59
15 minutes delayed
Stocks
+0.10
+0.88%
Today's range
10.90 - 11.78
ISIN
N/A
Source
NASDAQ
Alumis to Participate in Upcoming September Investor Conferences
03 Sep 2024 15:29:30 By Nasdaq GlobeNewswire
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
13 Aug 2024 15:05:27 By Nasdaq GlobeNewswire
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
29 Jul 2024 07:00:00 By Nasdaq GlobeNewswire